Analyst Ratings for Ventrus Biosciences (VTUS) [Buys]
VTUS Rating Summary
VTUS Price Target Summary
- Highest: $30.00 (William Blair)
- Lowest: $7.00 (Cantor Fitzgerald)
- Average: $22.75
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$22.75 (+724.3%)
Avg. $ Target:
$22.75 (+724.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/10/2012 | Cantor Fitzgerald » Updated 11/14/2012 |
Upgrade | Buy (Hold) |
7.00 (7.00) |
3.68 | 2.76 | -25% | Details |
| 6/14/2012 | Brean Capital | New Coverage | Buy (N/A) |
30.00 (N/A) |
10.04 | 2.76 | -72.51% | Details |
| 4/4/2012 | William Blair | New Coverage | Outperform (N/A) |
30.00 (N/A) |
10.04 | 2.76 | -72.51% | Details |
| 7/25/2011 | Lazard Capital | New Coverage | Buy (N/A) |
24.00 (N/A) |
11.89 | 2.76 | -76.79% | Details |
| 7/25/2011 | Leerink Swann | New Coverage | Outperform (N/A) |
N/A (N/A) |
11.89 | 2.76 | -76.79% | Details |
| 2/2/2011 | Rodman & Renshaw | New Coverage | Market Outperform (N/A) |
N/A (N/A) |
6.14 | 2.76 | -55.05% | Details |
| 1/27/2011 | National Securities | New Coverage | Buy (N/A) |
N/A (N/A) |
6.41 | 2.76 | -56.94% | Details |
